Stocks To Buy Forum

Stocks to Buy based on the Best Stock Market Research

Pfizer has the only FDA-approved drug in a class called CCR5 antagonists. A "cure for HIV" will most likely focus on CCR5, top scientist say.

 

If not by Pfizer's maraviroc, then a next-generation version of it could be part of the long-awaited cure. This isn't like fusion energy, where the breakthrough is always 30 years away. In this case, a conservative bet is 10 years. Actually, a cure for HIV has been demonstrated in one patient, which amounts to a proof of concept.

 

Some background:

 

Mutations in human genes cause muscular dystrophy, but a mutation in the CCR5 gene has a huge health benefit: people with it are almost completely resistant to HIV infection. Since that discovery was made in 1996, Pfizer and other pharmaceutical companies have become focused on developing a treatment that mimics the effects of a CCR5 mutation.

 

Here is a summary I wrote that describes the race for a cure for HIV -- http://bit.ly/OGbWQn

Tags: AIDS, Pfizer, biotechnology, pharmaceuticals

Views: 162

Attachments:

Reply to This

Subscription Service

Top Stocks to Buy on Dips: 2014

Noodles & Co (NDLS)
Yelp (YELP)
Twitter (TWTR)
Facebook (FB)
Tesla (TSLA)
Zillow (Z)
SolarCity (SCTY)
Small Cap 3x Bull (TNA)

 

Twitter - Free Stock Alerts

Like Us on Facebook

Stock Alerts

- Subscribe Via RSS Feed or - Subscribe to Stocks To Buy by Email



Upcoming IPO's 2014

Buy Oil Stocks 2014

What Stocks to Buy? Oil prices continue to rise and oil stocks are a good buy for the long term. For oil stock ideas, check out the latest hot shale plays in the US.

Utica Shale
Bakken Shale
Eagle Ford Shale

Niobrara Shale

Smackover Brown Dense
Tuscaloosa Marine Shale

© 2014   Created by Stocks To Buy.

Badges  |  Report an Issue  |  Terms of Service